About this trial
Population aging has become a significant global concern, and Taiwan is set to officially enter the "super-aged society" in 2025. As individuals age, various physiological functions gradually decline, including a reduction in muscle mass, which is a key aspect of the aging process.
This interventional study aims to investigate the effects of leucine-rich protein combined with polyunsaturated fatty acid supplementation on middle-aged and elderly individuals (aged 50 and above) who are at high risk for sarcopenia.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥ 50 years
ASMI < 7 kg/m2 in men
ASMI < 5.7 kg/m2 in women
Grip strength < 28 kg in men
Disqualifiers
People who are allergic to supplements
cancer
heart failure
kidney disease
Trial design
Parallel
Treatments tested in this trial
Animal-Based Oil Group
Dietary supplementParticipants in animal-based oil group will follow a diet in which the primary fat source is animal-based oil. The diet will supplement for 12 weeks.
Plant-Based Oil Group
Dietary supplementParticipants in plant-based oil group will follow a diet in which the primary fat source is plant-based oil. The diet will supplement for 12 weeks.
Treatment groups
Trial outcomes
Primary outcomes
muscle mass
Utilize Bioelectrical Impedance Analysis (BIA) to measure the Appendicular Skeletal Muscle Mass Index Level (ASMI) (kg/m\^2)
muscle function
utilize handgrip dynamometer to measure the hand grip strength (kg).
physical function
To assess the participant's walking speed over a 4-meter distance.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Chang Gung Memorial Hospital
Lead sponsor
Chang Gung University
Collaborator